Literature DB >> 2787092

The importance of C3d estimation in the diagnosis of generalized bacterial infections in newborn infants.

B Guillois1, C Berthou, H Awad, B Bendaoud, M G Guillemin, D Alix, P Youinou.   

Abstract

We evaluated the clinical relevance of a new C3d test in generalized bacterial neonatal infections. C3d was qualitatively evaluated by using an original counterimmunoelectrophoresis technique in 171 plasma. There were 13 cases of bacteriologically proven cases of septicemia and/or meningitis, 6 cases of probable and 42 cases of possible generalized infection. One hundred and ten non-infected samples were also tested. The sensitivity, specificity, positive and negative predictive values were 73.6, 83.6, 43.7 and 94.8%, respectively. The numbers of false positive and false negative were therefore found to be close to those observed when using classical infection markers.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787092     DOI: 10.1111/j.1651-2227.1989.tb11094.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  4 in total

Review 1.  Early diagnosis and treatment of neonatal sepsis.

Authors:  J S Gerdes; R Polin
Journal:  Indian J Pediatr       Date:  1998 Jan-Feb       Impact factor: 1.967

2.  Complement anaphylatoxin C3a and C5a formation in premature children with respiratory distress.

Authors:  A Enskog; A Bengtsson; J P Bengtson; M Heideman; S Andreasson; L Larsson
Journal:  Eur J Pediatr       Date:  1996-01       Impact factor: 3.183

3.  Complement fragment C3a in plasma of asphyxiated neonates.

Authors:  L Schrod; G Frauendienst-Egger; H B von Stockhausen; M Kirschfink
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

4.  Evaluation of altitude-appropriate reference ranges for neutrophils in diagnosis of sepsis in very low birth weight infants: A multicenter retrospective study.

Authors:  Jianhui Wang; Jialin Yu; Juan Fan; Yu He; Wenhui Dong; Zhengli Wang
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.